| Issue |
Section |
Title |
File |
| Vol 20, No 3 (2018) |
Articles |
Clinical prognostic factors of bilateral synchronous renal cancer |
(Rus)
|
| Vol 23, No 2 (2021) |
CLINICAL ONCOLOGY |
Prostate cancer |
(Rus)
|
| Vol 24, No 2 (2022) |
CLINICAL ONCOLOGY |
Cabozantinib in the treatment of patients with advanced renal cell carcinoma |
(Rus)
|
| Vol 25, No 1 (2023) |
CLINICAL ONCOLOGY |
Effect of transfused donor and autoerythrocytes on the oncological outcomes of surgical treatment in patients with renal cell carcinoma with tumor-related venous thrombosis: observational study |
(Rus)
|
| Vol 25, No 1 (2023) |
CLINICAL ONCOLOGY |
Updates in urologic oncology guidelines: prostate cancer: A review |
(Rus)
|
| Vol 25, No 2 (2023) |
CLINICAL ONCOLOGY |
Safety and toxicity of cabozantinib monotherapy in patients with advanced renal cell carcinoma: a Russian multicenter observational study |
(Rus)
|
| Vol 25, No 2 (2023) |
CLINICAL ONCOLOGY |
Updates in urologic oncology guidelines: renal cell carcinoma. A review |
(Rus)
|
| Vol 25, No 2 (2023) |
CLINICAL ONCOLOGY |
Updates in urologic oncology guidelines: urothelial carcinoma. A review |
(Rus)
|
| Vol 26, No 1 (2024) |
Articles |
Toxicity and safety of the combination of lenvatinib with pembrolizumab in patients with advanced renal cell cancer: The Russian phase IV observational study |
(Rus)
|
| Vol 26, No 1 (2024) |
Articles |
Outcomes of extracorporeal partial nephrectomy in patients with malignant tumors: a retrospective and prospective study |
(Rus)
|
| Vol 26, No 3 (2024) |
Articles |
Comparative analysis of efficacy and safety of combined immunotherapy and immune targeted therapy in the first-line treatment of advanced renal cell carcinoma: a real-world study |
(Rus)
|
| Vol 27, No 1 (2025) |
Articles |
Efficacy and safety of immunotherapy for metastatic renal cell carcinoma: A retrospective study |
(Rus)
|
| Vol 26, No 3 (2024) |
Articles |
The combination of lenvatinib and pembrolizumab in the treatment of patients with metastatic kidney cancer and factors of poor prognosis: experience of clinics in Moscow: A prospective observational study |
(Rus)
|
| Vol 26, No 4 (2024) |
Articles |
Experience of Next-Generation Sequencing in urothelial carcinoma specimens with panel for 523 genes |
(Rus)
|
